Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 7241829, 11 pages
http://dx.doi.org/10.1155/2016/7241829
Research Article

Periostin: A Downstream Mediator of EphB4-Induced Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells

1National & Regional United Engineering Laboratory of Tissue Engineering, Third Military Medical University, Chongqing 400038, China
2Department of Orthopaedics, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
3Department of Biomedical Materials Science, School of Biomedical Engineering, Third Military Medical University, Chongqing 400038, China

Received 17 June 2015; Revised 5 August 2015; Accepted 24 August 2015

Academic Editor: Susan Liao

Copyright © 2016 Fei Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Zhao, N. Irie, Y. Takada et al., “Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis,” Cell Metabolism, vol. 4, no. 2, pp. 111–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. F. M. Takyar, S. Tonna, P. W. M. Ho et al., “EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone,” Journal of Bone and Mineral Research, vol. 28, no. 4, pp. 912–925, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Matsuo and N. Irie, “Osteoclast–osteoblast communication,” Archives of Biochemistry and Biophysics, vol. 473, no. 2, pp. 201–209, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Ivaska and J. Heino, “Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix,” Cellular and Molecular Life Sciences, vol. 57, no. 1, pp. 16–24, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Anselme, “Osteoblast adhesion on biomaterials,” Biomaterials, vol. 21, no. 7, pp. 667–681, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Merle and P. Garnero, “The multiple facets of periostin in bone metabolism,” Osteoporosis International, vol. 23, no. 4, pp. 1199–1212, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Bonnet, S. J. Conway, and S. L. Ferrari, “Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 37, pp. 15048–15053, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Horiuchi, N. Amizuka, S. Takeshita et al., “Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor β,” Journal of Bone and Mineral Research, vol. 14, no. 7, pp. 1239–1249, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Wen, E. Chau, L. Jackson-Boeters, C. Elliott, T. D. Daley, and D. W. Hamilton, “TGF-β1 and FAK regulate periostin expression in PDL fibroblasts,” Journal of Dental Research, vol. 89, no. 12, pp. 1439–1443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Inai, R. A. Norris, S. Hoffman, R. R. Markwald, and Y. Sugi, “BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis,” Developmental Biology, vol. 315, no. 2, pp. 383–396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Jaiswal, S. E. Haynesworth, A. I. Caplan, and S. P. Bruder, “Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro,” Journal of Cellular Biochemistry, vol. 64, no. 2, pp. 295–312, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Zhang, Z. Zhang, D. Sun, S. W. Dong, J. Xu, and F. Dai, “EphB4 promotes osteogenesis of CTLA4-modified bone marrow-derived mesenchymal stem cells through cross talk with Wnt pathway in xenotransplantation,” Tissue Engineering Part A, vol. 21, no. 17-18, pp. 2404–2416, 2015. View at Publisher · View at Google Scholar
  13. A. Pennisi, W. Ling, X. Li et al., “The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth,” Blood, vol. 114, no. 9, pp. 1803–1812, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Brunner, P. Jurdic, J. P. Tuckerman, M. R. Block, and D. Bouvard, “New insights into adhesion signaling in bone formation,” International Review of Cell and Molecular Biology, vol. 305, pp. 1–68, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. L. A. Hidalgo-Bastida and S. H. Cartmell, “Mesenchymal stem cells, osteoblasts and extracellular matrix proteins: enhancing cell adhesion and differentiation for bone tissue engineering,” Tissue Engineering—Part B: Reviews, vol. 16, no. 4, pp. 405–412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Datta, H. L. Holtorf, V. I. Sikavitsas, J. A. Jansen, and A. G. Mikos, “Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells,” Biomaterials, vol. 26, no. 9, pp. 971–977, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. H. Damsky, “Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling,” Bone, vol. 25, no. 1, pp. 95–96, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Galli, M. Piergianni, M. Piemontese et al., “Periostin improves cell adhesion to implantable biomaterials and osteoblastic differentiation on implant titanium surfaces in a topography-dependent fashion,” Journal of Biomedical Materials Research—Part A, vol. 102, no. 11, pp. 3855–3861, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. L. Su, J. Chiou, C. H. Tang et al., “CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway,” The Journal of Biological Chemistry, vol. 285, no. 41, pp. 31325–31336, 2010. View at Google Scholar
  20. Y. S. Park, S. Hwang, Y. M. Jin et al., “CCN1 secreted by tonsil-derived mesenchymal stem cells promotes endothelial cell angiogenesis via integrin αvβ3 and AMPK,” Journal of Cellular Physiology, vol. 230, no. 1, pp. 140–149, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Gerbaix, L. Vico, S. L. Ferrari, and N. Bonnet, “Periostin expression contributes to cortical bone loss during unloading,” Bone, vol. 71, pp. 94–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Bonnet, E. Gineyts, P. Ammann, S. J. Conway, P. Garnero, and S. Ferrari, “Periostin deficiency increases bone damage and impairs injury response to fatigue loading in adult mice,” PLoS ONE, vol. 8, no. 10, Article ID e78347, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. C. Heo, W. C. Shin, M. J. Lee et al., “Periostin accelerates bone healing mediated by human mesenchymal stem cell-embedded hydroxyapatite/tricalcium phosphate scaffold,” PLOS ONE, vol. 10, no. 3, Article ID e0116698, 2015. View at Publisher · View at Google Scholar
  24. A. Oshima, H. Tanabe, T. Yan, G. N. Lowe, C. A. Glackin, and A. Kudo, “A novel mechanism for the regulation of osteoblast differentiation: transcription of periostin, a member of the fasciclin I family, is regulated by the bHLH transcription factor, Twist,” Journal of Cellular Biochemistry, vol. 86, no. 4, pp. 792–804, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Litvin, A.-H. Selim, M. O. Montgomery et al., “Expression and function of periostin-isoforms in bone,” Journal of Cellular Biochemistry, vol. 92, no. 5, pp. 1044–1061, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Mertens-Walker, B. C. Fernandini, M. S. Maharaj et al., “The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of Integrin-β8 in prostate cancer cells,” BMC Cancer, vol. 15, article 164, 2015. View at Publisher · View at Google Scholar
  27. M. Li, J. Zhao, J. Qiao, C. Song, and Z. Zhao, “EphB4 regulates the growth and migration of pancreatic cancer cells,” Tumor Biology, vol. 35, no. 7, pp. 6855–6859, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. B. D. Ferguson, R. Liu, C. E. Rolle et al., “The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target,” PLoS ONE, vol. 8, no. 7, Article ID e67668, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. M. G. Coulthard, M. Morgan, T. M. Woodruff et al., “Eph/ephrin signaling in injury and inflammation,” The American Journal of Pathology, vol. 181, no. 5, pp. 1493–1503, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. P. Himanen, “Ectodomain structures of Eph receptors,” Seminars in Cell and Developmental Biology, vol. 23, no. 1, pp. 35–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. P. W. Janes, E. Nievergall, and M. Lackmann, “Concepts and consequences of Eph receptor clustering,” Seminars in Cell and Developmental Biology, vol. 23, no. 1, pp. 43–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. T. J. Martin, E. H. Allan, P. W. M. Ho et al., “Communication between ephrinB2 and EphB4 within the osteoblast lineage,” in Osteoimmunology, vol. 658, pp. 51–60, Springer, 2009. View at Google Scholar
  33. S. Tonna, F. M. Takyar, C. Vrahnas et al., “EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis,” The FASEB Journal, vol. 28, no. 10, pp. 4482–4496, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. E. G. Tierney, K. McSorley, C. L. Hastings et al., “High levels of ephrinB2 over-expression increases the osteogenic differentiation of human mesenchymal stem cells and promotes enhanced cell mediated mineralisation in a polyethyleneimine-ephrinB2 gene-activated matrix,” Journal of Controlled Release, vol. 165, no. 3, pp. 173–182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. E. H. Allan, K. D. Häusler, T. Wei et al., “EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts,” Journal of Bone and Mineral Research, vol. 23, no. 8, pp. 1170–1181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. T. F. Day, X. Guo, L. Garrett-Beal, and Y. Yang, “Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis,” Developmental Cell, vol. 8, no. 5, pp. 739–750, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. T. P. Hill, D. Später, M. M. Taketo, W. Birchmeier, and C. Hartmann, “Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes,” Developmental Cell, vol. 8, no. 5, pp. 727–738, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. J. A. Kennell and O. A. MacDougald, “Wnt signaling inhibits adipogenesis through β-catenin-dependent and -independent mechanisms,” Journal of Biological Chemistry, vol. 280, no. 25, pp. 24004–24010, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Baron and G. Rawadi, “Minireview: targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton,” Endocrinology, vol. 148, no. 6, pp. 2635–2643, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. A. J. Harwood, “Regulation of GSK-3: a cellular multiprocessor,” Cell, vol. 105, no. 7, pp. 821–824, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Baron and M. Kneissel, “WNT signaling in bone homeostasis and disease: from human mutations to treatments,” Nature Medicine, vol. 19, no. 2, pp. 179–192, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Martiny-Baron, P. Holzer, E. Billy et al., “The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis,” Angiogenesis, vol. 13, no. 3, pp. 259–267, 2010. View at Publisher · View at Google Scholar · View at Scopus